TFChem

Rouen, France Founded: 2007 • Age: 19 yrs
Fluoride chemistry is utilized to design glycomimetic drug compounds.

About TFChem

TFChem is a Healthcare company based in Rouen (France) founded in 2007. Fluoride chemistry is utilized to design glycomimetic drug compounds. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Glycobiology.

Company details

TFChem was established in 2007 in Rouen, France, as a drug discovery entity within the biotechnology sector. Fluoride-modified carbohydrate compounds are developed for therapeutics addressing cancer, diabetes, cardiovascular diseases, pain, and inflammation. The GlycoMim platform is employed to enhance stability, bioavailability, and selectivity of these molecules. Collaborations with pharmaceutical firms are pursued for candidate advancement, while internal programs are operated. The company functions as a subsidiary of Sirona Biochem Corp.

Key Metrics

Funding Insights of TFChem

  • Total Rounds 2
  • Investors Count 5

All 2 funding rounds of TFChem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2022Grant––
Jun 2012Grant––
Valuation history

5 investors in total: 5 institutional.

Investors in TFChem

TFChem has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include CNRS, University of Rouen Normandie and INSA Rouen Normandy.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
gouvernement.fr
Multiple courses and degrees are offered in diversified academic streams.
1966univ-rouen.frFrance
Engineering courses are delivered by INSA Rouen Normandy center.
1985insa-rouen.fr
Scientific research across multiple fields is conducted by CNRS.
1939cnrs.frParis, France
economie.gouv.fr
Premium access

Investor details for TFChem

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of TFChem

3 dated milestones of TFChem across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded TFChem is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant,.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tfchem

Premium access

Complete news archive for TFChem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TFChem

TFChem was founded in 2007 and raised its 1st funding round 5 years after it was founded.

TFChem is headquartered in Rouen, France. It is registered at Rouen, Normandie, France.

TFChem was established in 2007 in Rouen, France, as a drug discovery entity within the biotechnology sector. Fluoride-modified carbohydrate compounds are developed for therapeutics addressing cancer, diabetes, cardiovascular diseases, pain, and inflammation. The GlycoMim platform is employed to enhance stability, bioavailability, and selectivity of these molecules. Collaborations with pharmaceutical firms are pursued for candidate advancement, while internal programs are operated. The company functions as a subsidiary of Sirona Biochem Corp.

TFChem has 5 investors. Key investors include CNRS, University of Rouen Normandie, INSA Rouen Normandy, Government of France, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available